Rheumatic Immune-Related Adverse Events—A Consequence of Immune Checkpoint Inhibitor Therapy

SIMPLE SUMMARY: Cancer therapy has evolved over the years, immunotherapy being the most used for untreatable malignant tumors. Immune checkpoint inhibitors decrease the ability of tumor cells to escape the immune system. Although immune checkpoint inhibitors have a significant impact in the treatmen...

Descripción completa

Detalles Bibliográficos
Autores principales: Bobircă, Anca, Bobircă, Florin, Ancuta, Ioan, Florescu, Alesandra, Pădureanu, Vlad, Florescu, Dan Nicolae, Pădureanu, Rodica, Florescu, Anca, Mușetescu, Anca Emanuela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8235766/
https://www.ncbi.nlm.nih.gov/pubmed/34203101
http://dx.doi.org/10.3390/biology10060561

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8235766/
https://www.ncbi.nlm.nih.gov/pubmed/34203101
http://dx.doi.org/10.3390/biology10060561

Ejemplares similares